Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Streamex Corp.BSGM · Entity 1816 | Chief Operating Officer | November 30, 2023 | December 05, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Streamex Corp.
Report date November 30, 2023 · Filed December 05, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 457,920 |
Reported balance
After 2023-11-30 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-11-30 · Grant · Acquired 92,300 · Balance 457,920 F1: On December 4th, 2023, the reporting person filed a Form 4, which inadvertently reported the award as a stock option (right to buy) instead of shares of restricted stock. F2: The shares of restricted stock fully vested on November 30, 2023, the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 4th, 2023, the reporting person filed a Form 4, which inadvertently reported the award as a stock option (right to buy) instead of shares of restricted stock.
F2: The shares of restricted stock fully vested on November 30, 2023, the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2023 Filed Dec 4, 2023 20:36 UTC | Streamex Corp. BSGM · Entity 1816 | GrantStock Option (Right to Buy) · Derivative | 92,300 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001493152-23-043624 · ownership.xml · derivative · entry 1 Sieckhaus John · CIK 0001921290 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,300 Underlying: Common Stock · 92,300 shares Expires 2033-11-30 F1 · derivative.exercise_date: This stock option fully vested on November 30, 2023, the date of grant, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 18:17 UTC Amendment | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 92,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-043762 · ownership.xml · nonDerivative · entry 1 Sieckhaus John · CIK 0001921290 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 457,920 F1 · security: On December 4th, 2023, the reporting person filed a Form 4, which inadvertently reported the award as a stock option (right to buy) instead of shares of restricted stock. F2 · price: The shares of restricted stock fully vested on November 30, 2023, the date of the grant. Read SEC document |
| May 05, 2023 Filed May 9, 2023 16:07 UTC | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 295,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-23-000463 · ownership.xml · nonDerivative · entry 1 Sieckhaus John · CIK 0001921290 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,620 Read SEC document |
| September 12, 2022 Filed Sep 12, 2022 14:42 UTC | Streamex Corp. BSGM · Entity 1816 | PurchaseCommon Stock | 5,000 | $0.91 | $4,550.00 |
DisclosureSEC source: 0001185185-22-001091 · ownership.xml · nonDerivative · entry 1 Sieckhaus John · CIK 0001921290 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 06:00 UTC | Streamex Corp. BSGM · Entity 1816 | PurchaseCommon Stock | 5,000 | $1.07 | $5,335.00 |
DisclosureSEC source: 0001185185-22-001042 · ownership.xml · nonDerivative · entry 1 Sieckhaus John · CIK 0001921290 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 F1 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.065 to $1.070, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 06:02 UTC | Streamex Corp. BSGM · Entity 1816 | PurchaseCommon Stock | 10,000 | $1.13 | $11,347.00 |
DisclosureSEC source: 0001185185-22-001012 · ownership.xml · nonDerivative · entry 1 Sieckhaus John · CIK 0001921290 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0965 to $1.18, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 30, 2022 Filed Apr 8, 2022 18:22 UTC | Streamex Corp. BSGM · Entity 1816 | GrantOptions · Derivative | 350,000 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001185185-22-000415 · ownership.xml · derivative · entry 2 Sieckhaus John · CIK 0001921290 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2032-03-30 F2 · derivative.exercise_date: The shares underlying this stock option will vest over three years, with 1/3 vesting on the first anniversary of March 30, 2022 and 2/3 vesting in substantially equal quarterly installments thereafter, subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan. Read SEC document |
| March 21, 2022 Filed Apr 8, 2022 18:22 UTC | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-22-000415 · ownership.xml · nonDerivative · entry 1 Sieckhaus John · CIK 0001921290 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · shares: The reporting person received the shares as a one-time signing bonus upon the commencement of the reporting person's employment with the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.